Journal: | Annals of hepatology |
Database: | PERIÓDICA |
System number: | 000416322 |
ISSN: | 1665-2681 |
Authors: | Mangano, Carmelo1 Squadrito, Giovanni2 Cacciola, Irene2 Carpentieri, Mariastella1 Foti, Giuseppe1 Raimondo, Giovanni2 |
Institutions: | 1Ospedale Bianchi-Melacrino-Morelli , Divisione delle Malattie Infetive, Reggio Calabria, Calabria. Italia 2Ospedale Accademico di Messina, Dipartimento di Medicina Interna, Messina, Sicilia. Italia |
Year: | 2011 |
Season: | Ene-Mar |
Volumen: | 10 |
Number: | 1 |
Pages: | 84-87 |
Country: | México |
Language: | Inglés |
Document type: | Artículo |
Approach: | Caso clínico, descriptivo |
English abstract | Hepatitis B virus (HBV) surface antigen (HBsAg) to anti-HBsAg (anti-HBs) antibody seroconversion is the best, final objective for all available chronic hepatitis B (CHB) treatments. Unfortunately, this goal is rarely obtained with the currently utilized therapeutic approaches. Here we describe the case of a CHB patient who was very successfully treated with a particular therapeutic schedule. The patient was initially treated with Lamivudine for four years. Subsequently, pegylated interferon alpha-2a was introduced for a period of one year. During this period of combined therapies, the patient showed a flare of aminotransferase values followed by complete normalization of liver biochemistry parameters and HBsAg/anti-HBs seroconversion that persisted up to 24 months after all therapies had been stopped |
Disciplines: | Medicina |
Keyword: | Gastroenterología, Terapéutica y rehabilitación, Hepatitis crónica, Virus de la hepatitis B, Terapia antiviral, Lamivudina, Peginterferón |
Keyword: | Gastroenterology, Therapeutics and rehabilitation, Chronic hepatitis, Hepatitis B virus, Antiviral therapy, Lamivudine, Pegylated interferon |
Full text: | Texto completo (Ver PDF) |